ArticleJournal of medical physics
Feasibility of Radiophotoluminescent Glass Dosimeter for Measuring Radiation Dose in Kilovoltage Cone-beam Computed Tomography.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Cone-beam computed tomography (CBCT) is widely used in imaging-guided radiotherapy for precise treatment planning and patient positioning. However, the ionizing radiation used in CBCT poses inherent risks to patients. Materials and Methods: This study evaluated the feasibility of radiophotoluminescent. glass dosimeter system GD-352M for measuring radiation dose in kilovoltage CBCT (kV-CBCT). Results: The GD-352M demonstrated good uniformity, linearity, accuracy, reproducibility, and low-energy dependence. Moreover, the FDG-1000 automatic reader system exhibited consistent readout values that were not influenced by the magazine's position. The GD-352M demonstrated good uniformity, linearity, and accuracy, with a combined measurement uncertainty of 4.56%, confirming its suitability for kV-CBCT dosimetry. Conclusion: These findings indicate the suitability of the GD-352M dosimeter for measuring dose range in kV-CBCT and improve patient safety in kV-CBCT dosimetry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.